Who owns TREACE MEDICAL CONCEPTS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TMCI from SEC Form 13F filings across 116 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 116 institutions disclosed 31.9M shares of TREACE MEDICAL CONCEPTS, INC. worth $126.8M — about 49% of shares outstanding; the largest disclosed holder is ARMISTICE CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
116
13F holders
$126.8M
value, 2026 filers
49%
of shares outstanding (31.9M sh)
31
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TMCI's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 6.4M | $25.3M | 0.3% | 9.8% | 0.0% |
| 2 | BANK OF AMERICA CORP /DE/ | 3.3M | $13.2M | 0.0% | 5.1% | +2.8% |
| 3 | GAGNON SECURITIES LLC | 3.0M | $12.1M | 2.3% | 4.7% | -41.8% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $8.1M | 0.0% | 3.1% | +38.8% |
| 5 | Gagnon Advisors, LLCNEW | 1.5M | $6.1M | 3.9% | 2.4% | new |
| 6 | AQR CAPITAL MANAGEMENT LLC | 1.5M | $6.0M | 0.0% | 2.3% | +41.0% |
| 7 | BlackRock, Inc. | 1.4M | $5.5M | 0.0% | 2.1% | -58.7% |
| 8 | MARSHALL WACE, LLP | 1.3M | $5.3M | 0.0% | 2% | +401.5% |
| 9 | CIBC Bancorp USA Inc. | 1.2M | $4.8M | 0.0% | 1.9% | -0.2% |
| 10 | ACADIAN ASSET MANAGEMENT LLC | 928,177 | $3.7M | 0.0% | 1.4% | -1.4% |
| 11 | MILLENNIUM MANAGEMENT LLC | 738,628 | $2.9M | 0.0% | 1.1% | -35.7% |
| 12 | WEBER CAPITAL MANAGEMENT LLC /ADV | 589,617 | $2.3M | 2.0% | 0.9% | 0.0% |
| 13 | D. E. Shaw & Co., Inc. | 583,277 | $2.3M | 0.0% | 0.9% | -30.7% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 573,796 | $2.3M | 0.0% | 0.9% | -43.2% |
| 15 | CITADEL ADVISORS LLC | 516,994 | $2.1M | 0.0% | 0.8% | -37.4% |
| 16 | GOLDMAN SACHS GROUP INC | 492,116 | $2.0M | 0.0% | 0.8% | +26.9% |
| 17 | STIFEL FINANCIAL CORP | 435,009 | $1.7M | 0.0% | 0.7% | +147.0% |
| 18 | UBS Group AG | 366,445 | $1.5M | 0.0% | 0.6% | -32.5% |
| 19 | JACOBS LEVY EQUITY MANAGEMENT, INC | 363,729 | $1.4M | 0.0% | 0.6% | +37.9% |
| 20 | RAYMOND JAMES FINANCIAL INC | 331,110 | $1.3M | 0.0% | 0.5% | -7.4% |
| 21 | MORGAN STANLEY | 320,026 | $1.3M | 0.0% | 0.5% | +45.7% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 292,504 | $1.2M | 0.0% | 0.4% | -8.0% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 282,538 | $1.1M | 0.0% | 0.4% | -14.1% |
| 24 | STATE STREET CORP | 234,271 | $932,399 | 0.0% | 0.4% | -81.0% |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 214,219 | $852,592 | 0.0% | 0.3% | +1156.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.